Astro Health to present AI dementia care platform at AAIC 2026

Astro Health will present a scientific poster at the Alzheimer’s Association International Conference 2026 in San Francisco on an AI-powered dementia care-support platform aimed at improving function and reducing falls. The company says the system is designed to extend personalized support for patients, caregivers and clinicians between care visits.

Why it matters: - Dementia affects more than 55 million people worldwide, and that number is projected to nearly triple by 2050 as populations age. - Astro Health is targeting a care gap that extends beyond clinic visits, where patients and caregivers often need ongoing support. - The platform is designed to improve functionality, promote independence and help reduce fall risk for people living with mild cognitive impairment and dementia.

What happened: - Astro Health announced a poster presentation at the Alzheimer’s Association International Conference (AAIC®) 2026. - The conference is the world’s largest international meeting focused on Alzheimer’s disease and dementia research. - The poster is titled “An Artificial Intelligence Powered Dementia Care-Support Platform For Improving Functionality And Reducing Falls.” - Shraddha Chaugule, Ph.D., founder and CEO of Astro Health, is leading the presentation. - Ian Thornell, M.S., and Eric Hsieh, M.D., of the Keck School of Medicine of USC are co-authors.

The details: - The platform uses a multi-agent artificial intelligence system. - The system combines personalized digital interventions, continuous monitoring, caregiver support and evidence-informed decision support. - Astro Health says the platform uses advanced large language models, multimodal health data and intelligent AI agents. - The platform is designed to deliver individualized care recommendations and monitor behavioral and functional changes. - The system also aims to facilitate caregiver engagement and support long-term disease management. - Astro Health says the platform is being developed to complement, not replace, clinical care. - The company’s broader research agenda spans aging, cognitive health, mental health and chronic disease management. - Astro Health continues to work with academic and clinical institutions to evaluate its technologies through scientific research.

Between the lines: - The AAIC appearance gives Astro Health a scientific forum to position its AI platform as a clinical support tool, not just a consumer health product. - The focus on personalization, continuous monitoring and caregiver support reflects a broader push in digital health toward care that happens between appointments. - The poster’s emphasis on falls suggests a practical, measurable outcome that could matter to patients, families and health systems.

What's next: - Astro Health will present the poster at AAIC 2026. - The company is expected to keep validating its platform through research collaborations with healthcare and academic partners. - Further development will likely center on demonstrating clinical impact across dementia and other aging-related conditions.

The bottom line: - Astro Health is using AAIC 2026 to showcase an AI dementia care platform built to extend support beyond the clinic and target functional decline and fall risk.